Resultats de la cerca - Alexandre Bazinet

PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromes per Alexandre Bazinet, Alex Bataller, Guillermo Montalban-Bravo, Kelly Chien, Koji Sasaki, Wei Ying Jen, Mahesh Swaminathan, Tapan Kadia, Courtney DiNardo, Farhad Ravandi, Guillermo Garcia-Manero, Hagop Kantarjian

Obtenir text complet

Outcomes of patients diagnosed with myelodysplastic syndrome or acute myeloid leukemia following solid organ transplantation per Charan Thej Reddy Vegivinti, Guillermo Montalban-Bravo, Kelly Chien, Danielle Hammond, Koji Sasaki, Alex Bataller, Ian Bouligny, Wei Ying Jen, Mahesh Swaminathan, Sanam Loghavi, Uday Popat, Guillermo Garcia-Manero, Alexandre Bazinet

Obtenir text complet

P500: SUPERIOR OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANTATION AMONG PATIENTS ≥ 60 YEARS TREATED WITH CLADRIBINE, LOW DOSE CYTARABINE PLUS VENETOCLAX FOR NEWLY DIAGNOSED ACUTE... per Jayastu Senapati, Hagop Kantarjian, Alexandre Bazinet, Patrick Reville, Gautam Borthakur, Naval Daver, Courtney Dinardo, Alex Bataller, Elias Jabbour, Nicholas Short, Uday R. Popat, Amin Majid Alousi, Elizabeth J. Shpall, Guillermo Garcia-Manero, Farhad Ravandi, Tapan Kadia

Obtenir text complet

S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN COMBINATION WITH VENETOCLAX IN TREATMENT-NAÏVE HIGHER-RISK MYELODYSPLASTIC SYNDROMES OR CHRONIC MYELOMONOCYTIC LEUKEMIA per Alex Bataller, Alexandre Bazinet, Sangeetha Venugopal, Guillermo Montalban-Bravo, Yesid Alvarado, Kelly Chien, Ghayas Issa, Nicholas Short, Danielle Hammond, Lucia Masarova, Tapan Kadia, Rashmi Kanagal-Shamanna, Stephany Hendrickson, Farhad Ravandi, Elias Jabbour, Hagop Kantarjian, Guillermo Garcia-Manero

Obtenir text complet

P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM DIAGNOSIS TO HYPOMETHYLATING AGENT FAILURE per Kelly Chien, Samuel Urrutia, Ziyi LI, Rashmi Kanagal-Shamanna, Emmanuel Almanza, Tareq Abuasab, Georgina Gener, Alex Bataller, Alexandre Bazinet, Guillermo Montalban-Bravo, Nicholas Short, Elias Jabbour, Tapan Kadia, Farhad Ravandi, Gautam Borthakur, Danielle Hammond, Mahesh Swaminathan, Koji Sasaki, Sherry Pierce, Hagop Kantarjian, Guillermo Garcia-Manero

Obtenir text complet

P736: ANALYSIS OF RESPONSE RATES AND OUTCOMES IN ERYTHROID-PREDOMINANT MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH VENETOCLAX-BASED REGIMENS per Alexandre Bazinet, Naszrin Arani, Kelly Chien, Danielle Hammond, Tapan Kadia, Gautam Borthakur, Yesid Alvarado, Koji Sasaki, Courtney Dinardo, Naveen Pemmaraju, Lucia Masarova, Nicholas Short, Musa Yilmaz, Naval Daver, Elias Jabbour, Farhad Ravandi, Rashmi Kanagal-Shamanna, Sherry Pierce, Hagop Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban-Bravo

Obtenir text complet

Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes per Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Feiyang Ma, Kelly Chien, Monica Del Rey, Sanam Loghavi, Guillermo Montalban-Bravo, Vera Adema, Bethany Wildeman, Rashmi Kanagal-Shamanna, Alexandre Bazinet, Helen T. Chifotides, Natthakan Thongon, Xavier Calvo, Jesús María Hernández-Rivas, Maria Díez-Campelo, Guillermo Garcia-Manero, Simona Colla

Obtenir text complet

Outcomes and genetic dynamics of acute myeloid leukemia at first relapse per Alex Bataller, Hagop Kantarjian, Alexandre Bazinet, Tapan Kadia, Naval Daver, Courtney D. DiNardo, Gautam Borthakur, Sanam Loghavi, Keyur Patel, Guilin Tang, Koji Sasaki, Nicholas J. Short, Musa Yilmaz, Ghayas C. Issa, Yesid Alvarado, Guillermo Montalban-Bravo, Abhishek Maiti, Hussein A. Abbas, Koichi Takahashi, Sherry Pierce, Elias Jabbour, Guillermo Garcia-Manero, Farhad Ravandi

Obtenir text complet

P723: CLINICAL AND MOLECULAR ASSOCIATIONS WITH OUTCOMES IN HIGHER RISK MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS PLUS VENETOCLAX per Alexandre Bazinet, Sai Prasad Desikan, Ziyi LI, Sangeetha Venugopal, Samuel Urrutia, Guillermo Montalban-Bravo, Koji Sasaki, Kelly Chien, Danielle Hammond, Rashmi Kanagal-Shamanna, Bailey Mirabella, Stephany Hendrickson, Liz Romero, Simona Colla, Irene Ganan-Gomez, Juan Jose Rodriguez-Sevilla, Tapan Kadia, Courtney Dinardo, Naval Daver, Elias Jabbour, Farhad Ravandi, Hagop Kantarjian, Guillermo Garcia-Manero

Obtenir text complet

A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome per Ian M. Bouligny, Guillermo Montalban-Bravo, Koji Sasaki, Naval Daver, Elias Jabbour, Yesid Alvarado, Courtney D. DiNardo, Farhad Ravandi, Gautam Borthakur, Prithviraj Bose, Naveen Pemmaraju, Steven Kornblau, Tapan Kadia, Lucia Masarova, Koichi Takahashi, Michael Andreeff, Alexandre Bazinet, Hui Yang, Rashmi Kanagal-Shamanna, Chitra Hosing, Sherry Pierce, Meghan Meyer, Xuelin Huang, Guillermo Garcia-Manero

Obtenir text complet

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia per Thura Win Htut, Jeannot Kekedjian, Nicholas Short, Alexandre Bazinet, Yesid Alvarado, Alex Bataller, Ghayas Issa, Gautam Borthakur, Abhishek Maiti, Musa Yilmaz, Nitin Jain, Lucia Masarova, Kelly Chien, Jayastu Senapati, Elias Jabbour, Guillermo Montalban-Bravo, Sherry Pierce, Courtney D DiNardo, Tapan Kadia, Naval Daver, Marina Konopleva, Xuelin Huang, Hagop Kantarjian, Guillermo Garcia-Manero, Farhad Ravandi

Obtenir text complet

Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score–matched study per Alex Bataller, Koji Sasaki, Samuel Urrutia, Guillermo Montalban-Bravo, Alexandre Bazinet, Kelly Chien, Danielle Hammond, Ian M. Bouligny, Mahesh Swaminathan, Ghayas Issa, Nicholas Short, Naval Daver, Courtney D. DiNardo, Tapan Kadia, Elias Jabbour, Farhad Ravandi, Gail J. Roboz, Michael Savona, Elizabeth A. Griffiths, James McCloskey, Olatoyosi Odenike, Aram Oganesian, Harold N. Keer, Mohammad Azab, Hagop Kantarjian, Guillermo Garcia-Manero

Obtenir text complet

Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients per Christophe Willekens, Alexandre Bazinet, Samy Chraibi, Alex Bataller, Justine Decroocq, Naszrin Arani, Benjamin Carpentier, Caitlin Rausch, Delphine Lebon, Abhishek Maiti, Nicolas Gauthier, Nicholas Short, Sarah Bonnet, Koji Sasaki, Sabine Khalife-Hachem, Mahesh Swaminathan, Jean-Baptiste Micol, Florence Pasquier, Christophe Marzac, Damien Roos-Weil, Laurent Pascal, Naval Daver, Tapan Kadia, Didier Bouscary, Farhad Ravandi, Arnaud Pages, Hagop Kantarjian, Stéphane De Botton, Courtney DiNardo

Obtenir text complet

Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes per Alexandre Bazinet, Alex Bataller, Kelly Chien, Koji Sasaki, Guillermo Montalban-Bravo, Danielle Hammond, Ian Bouligny, Mahesh Swaminathan, Wei Ying Jen, Eitan Kugler, Rashmi Kanagal-Shamanna, Tapan Kadia, Gautam Borthakur, Courtney DiNardo, Nicholas Short, Naveen Pemmaraju, Elias Jabbour, Naval Daver, Farhad Ravandi, Samuel Urrutia, Georgina Gener-Ricos, Julie Braish, Robert Briski, Juan Jose Rodriguez-Sevilla, Ziyi Li, Richard E. Champlin, Elizabeth J. Shpall, Amin Alousi, Betul Oran, Chitra Hosing, Jeremy L. Ramdial, Amanda Olson, Sherry Pierce, Julianne Chen, Hagop Kantarjian, Guillermo Garcia-Manero, Uday Popat

Obtenir text complet